19th Jan 2021 15:04
Shield Therapeutics PLC - Newcastle, England-based pharmaceutical firm focussed on iron deficiency - Chief Executive Officer Tim Watts buys 100,000 shares at GBP0.60, worth GBP60,250, on Tuesday. Watts also bought 100,000 shares in December. Now has 748,700 shares.
Current stock price: 58.00 pence
Year-to-date change: down 8.7%
By Tom Waite; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
Shield Thera